|本期目录/Table of Contents|

[1]张扬,管得宁,徐运.跌倒恐惧对帕金森病患者生活质量的影响[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):6-10.[doi:10.3969/j.issn.1672-271X.2018.01.002]
　ZHANG Yang,GUAN De-ning,XU Yun.Impact of fear of falling on quality of life in patients with Parkinson′s disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(01):6-10.[doi:10.3969/j.issn.1672-271X.2018.01.002]
点击复制

跌倒恐惧对帕金森病患者生活质量的影响()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第20卷
期数:
2018年01期
页码:
6-10
栏目:
出版日期:
2018-01-22

文章信息/Info

Title:
Impact of fear of falling on quality of life in patients with Parkinson′s disease
作者:
张扬; 管得宁; 徐运
作者单位：210008 南京，南京大学医学院附属鼓楼医院神经内科(张扬、管得宁、徐运)
Author(s):
ZHANG Yang; GUAN De-ning; XU Yun
（Department of Neurology，the Affiliated Drum Tower Hospital, Medical College of Nanjing University, Nanjing 210008, Jiangsu, China）
关键词:
帕金森病; 跌倒恐惧; 生活质量
Keywords:
Parkinson′s disease;  fear of falling;  quality of life
分类号:
R737.9
DOI:
10.3969/j.issn.1672-271X.2018.01.002
文献标志码:
A
摘要:
目的 探讨跌倒恐惧对帕金森病患者生活质量的影响。方法 纳入2013年6月至2015年12月期间在南京鼓楼医院就诊的帕金森病患者96例，依据活动平衡信心量表（ABC量表）将患者分为跌倒恐惧组（46例）和无跌倒恐惧组（50例）。采集入组患者的一般信息，包括性别、年龄、病程、受教育年限、药物治疗等基线情况。采用中文版帕金森病患者生活质量问卷（PDQ-39）来评估最近1个月内的生活质量状况。以Hoehn-Yahr分级、统一帕金森病评分量表的运动评分（UPDRS-Ⅲ）、跌倒史等来评估受试者运动相关的临床特征。应用简易精神状态量表（MMSE）、汉密尔顿抑郁量表（HAMD）、汉密尔顿焦虑量表（HAMA）来评估常见非运动症状的临床特征。 结果 帕金森病伴跌倒恐惧组病程明显长于无跌倒恐惧组（P<005）。跌倒恐惧组在UPDRS-Ⅲ、HAMA、左旋多巴等效剂量等相关因素均明显高于无跌倒恐惧组（P<005）。在PDQ-39量表的比较方面，跌倒恐惧组在PDQ-39总得分指数（PDQ-39 SI）、身体活动、日常生活行为、精神健康、屈辱感、认知、交流以及身体不适等方面的评分均比无跌倒恐惧组高（P<005）。在相关性分析方面，跌倒恐惧组ABC评分与病程、UPDRS-Ⅲ、跌倒史、HAMA等均呈显著负相关（r=-0.418、-0.541、-0.366、-0.378，P<005），在与PDQ-39各维度的相关性分析显示ABC评分与PDQ-39 SI、身体活动、日常生活行为、精神健康、交流、身体不适维度呈显著负相关（r=-0.713、-0.483、-0.671、-0.315、-0.349、-0.377，P<005）。其中，ABC评分与身体活动及日常生活行为两个维度的相关性最高（P<001）。结论 跌倒恐惧对帕金森病患者生活质量有显著的影响，跌倒恐惧的严重程度与患者的生活质量显著相关。临床上如重视改善帕金森病患者跌倒恐惧的状况，可有效提高患者生活质量。
Abstract:
Objective The purpose of this study is to investigate the quality of life (QoL) that affected by fear of falling (FOF) with Parkinson′s disease (PD).Methods Ninety six PD patients were recruited between June 2013 and December 2015 from the department of Neurology, Drum tower Hospital, Medical school of Nanjing University. According to the Activities-specific Balance Confidence scale (ABC scale), PD patients were divided into two groups: PD with FOF (n=46) and PD without FOF (n=50). The baseline characteristics were collected, such as age, gender, duration and medical treatment, etc. The 39-item Parkinson′s Disease Questionnaire (PDQ-39) was used to evaluate the QoL of all PD patients. Hoehn-Yahr(H-Y) stage, Unified Parkinson Disease Rating Scale (UPDRS)-Ⅲ, history of falling within one year were used to evaluate movement symptoms. Mini Mental State Examination (MMSE),Hamilton Depression Scale (HAMD) and Hamilton Anxiety Scale (HAMA) were used to evaluate non-motor symptoms.Results A total of 96 PD patients participated in the research. The duration of disease of FOF group was longer than non-FOF group (P＜0.05). PD with FOF group was more severe than non-FOF group in UPDRS-Ⅲ, HAMA, Levodopa Equivalent Dose (LED) (P＜0.05). As to QoL, FOF group was more severe than non-FOF group in the domain of PDQ-39 scoring for single index (PDQ-39 SI), mobility, activities of daily living, emotional well-being, stigma, cognitions, communication, bodily discomfort (P＜0.05). In the analysis of correlation, the ABC scale score of FOF group showed significant negative correlation with duration, UPDRS- Ⅲ, falling history and HAMA (r=-0.418，-0.541，-0.366，-0.378, P＜0.05). In the correlation analysis of PDQ-39, the ABC scale score of FOF group showed significant negative correlation with PDQ-39 SI, mobility, activities of daily living, emotional well-being, communication, bodily discomfort (r=-0.713，-0.483，-0.671，-0.315，-0.349，-0.377, P＜0.05).Conclusion The QoL is influenced by FOF in PD patients. The severity of FOF is correlated with QoL significantly. Through alleviate the severity of FOF, the QoL of PD patients will be improved.

参考文献/References:

[1]Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson′s disease: a systematic review [J]. Parkinson′s Dis, 2013, 2013:906274. doi: 10.1155/2013/906274.[2]Pickering RM, Grimbergen YA, Rigney U, et al. A meta-analysis of six prospective studies of falling in Parkinson′s disease [J]. Mov Disord, 2007, 22(13):1892-1900.[3]魏红，包维为，李斌，等. 老年人致跌的相关环境危险因素分析[J]. 东南国防医药，2014, 16(2):168-170.[4]Nomura T, Futaki T, Notoya M. Factors affecting activity restriction associated with fear of falling in elderly Japanese [J]. J Tsuruma Hearth Sci Soc, 2008, 31(2):15-24. [5]Lindholm B, Hagell P, Hansson O, et al. Factors associated with fear of falling in people with Parkinson′s disease [J]. BMC Neurol, 2014,14:19. doi: 10.1186/1471-2377-14-19.[6]Nilsson MH, Hariz GM, Wictorin K, et al. Development and testing of a self administered version of the Freezing of Gait Questionnaire [J]. BMC Neurol, 2010, 10:85. doi: 10.1186/1471-2377-10-85.[7]Deshpande N, Metter EJ, Lauretani F, et al. Activity restriction induced by fear of falling and objective and subjective measures of physical function: a prospective cohort study [J]. J Am Geriatr Soc, 2008, 56(4):615-620.[8]Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson′s disease: a clinico-pathological study of 100 cases [J]. J Neurol Neurosurg Psychiatry, 1992, 55(3):181-184.[9]Lohnes CA, Earhart GM. External validation of abbreviated versions of the activities-specific balance confidence scale in Parkinson′s disease [J]. Mov Disord, 2010, 25(4):485-489. [10]Mak MK, Pang MY. Fear of falling is independently associated with recurrent falls in patients with Parkinson′s disease: a 1-year prospective study [J]. J Neurol, 2009, 256(10):1689-1695.[11]Zhang JL, Chan P. Reliability and validity of PDQ-39: a quality-of-life measure for patients with PD in China [J]. Qual Life Res, 2012, 21(7):1217-1221. [12]Thomas AA, Rogers JM, Amick MM, et al. Falls and the falls efficacy scale in Parkinson′s disease [J]. J Neurol, 2010, 257(7):1124-1128.[13]Nilsson MH, Rehncrona S, Jarnlo GB. Fear of falling and falls in people with Parkinson′s disease treated with deep brain stimulation in the subthalamic nuclei [J]. Acta Neurol Scand, 2011,123 (6):424-429.[14]Mak MK, Pang MY. Parkinsonian single fallers versus recurrent fallers: different fall characteristics and clinical features [J]. J Neurol, 2010,257(9):1543-1551.[15]Kurlan R. “Fear of falling” gait: a potentially reversible psychogenic gait disorder [J]. Cogn Behav Neurol, 2005,18(3):171-172.[16]Rahman S, Griffin HJ, Quinn NP, et al. On the nature of fear of falling in Parkinson′s disease [J]. Behav Neurol, 2011,24(3):219-228.[17]Brozova H, Stochl J, Roth J, et al. Fear of falling has greater influence than other aspects of gait disorders on quality of life in patients with Parkinson′s disease [J]. Neuro Endocrinol Lett, 2009, 30(4):453-456.[18]Delbaere K, Crombez G, Vanderstraeten G, et al. Fear-related avoidance of activities, falls and physical frailty. A prospective community-based cohort study [J]. Age Ageing, 2004, 33 (4):368-373.[19]Deshpande N, Metter EJ, Lauretani F, et al. Activity restriction induced by fear of falling and objective and subjective measures of physical function: a prospective cohort study [J]. J Am Geriatr Soc,2008, 56(4):615-620.[20]Landers MR, Lopker M, Newman M, et al. Cross-sectional analysis of the characteristics of individuals with Parkinson′s disease who avoid activities and participation due to fear of falling [J]. J Neurol Phys Ther, 2017, 41(1):31-42.[21]Sparrow D, DeAngelis TR, Hendron K, et al. Highly challenging balance program reduces fall rate in Parkinson disease [J]. J Neurol Phys Ther, 2016, 40(1):24-30.

相似文献/References:

[1]胡 晓,王 省,闫福岭,等.帕金森病患者便秘发生情况的临床观察[J].医学研究与战创伤救治(原医学研究生学报),2013,15(04):332.[doi:10.3969/j.issn.1672-271X.2013.04.004]
　HU Xiao,WANG Xing,YAN Fu-ling,et al.Clinic investigation of constipation in Parkinson's disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2013,15(01):332.[doi:10.3969/j.issn.1672-271X.2013.04.004]
[2]于苏文,郑秀琴,陈红霞,等.高频重复经颅磁刺激治疗帕金森病临床疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2010,12(02):109.
　YU Su-wen,ZHENG Xiu-qin,CHEN Hong-xia,et al.Clinicalal study of treating Parkinsons disease by repetitively transcranial magnetic stimulation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(01):109.
[3]曾 志,张国兴,陈基敏.代谢热层像诊断帕金森病5例报告[J].医学研究与战创伤救治(原医学研究生学报),2008,10(01):6.
[4]余志阳,潘士勇,刘清珍,等.丙泊酚对帕金森小鼠黑质多巴胺能神经元凋亡的影响[J].医学研究与战创伤救治(原医学研究生学报),2015,17(04):346.[doi:10.3969/j.issn.1672-271X.2015.04.003]
　YU Zhi-yang,PAN Shi-Yong,LIU Qing-zhen,et al.The effect of propofol on apoptosis of dopaminergic neurons in the substantia nigra of mouse model of Parkinson’s disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2015,17(01):346.[doi:10.3969/j.issn.1672-271X.2015.04.003]
[5]杨雅玲,刘华斌,林庆金.枸橼酸坦度螺酮治疗帕金森病异动症的疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2021,23(02):146.[doi:10.3969/j.issn.1672-271X.2021.02.008]
　YANG Ya-ling,LIU Hua-bin,LIN Qing-jin.Therapeutic effect of tandorone citrate on Parkinson’s disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(01):146.[doi:10.3969/j.issn.1672-271X.2021.02.008]
[6]戴为正,吴美娜,傅懋林,等.普拉克索联合高频重复经颅磁刺激治疗早期帕金森病合并抑郁患者的临床疗效观察[J].医学研究与战创伤救治(原医学研究生学报),2021,23(6):592.[doi:10.3969/j.issn.1672-271X.2021.06.007]
　DAI Wei-zheng,WU Mei-na,FU Mao-lin,et al.Observation on clinical effects of pramipexole combined with high-frequency repetitive transcranial magnetic stimulation (rTMS) in the treatment of patients suffered from early Parkinson’s disease (PD) and depression[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2021,23(01):592.[doi:10.3969/j.issn.1672-271X.2021.06.007]

备注/Memo

备注/Memo:
基金项目：中央高校基本科研业务费专项基金（021414380290）
更新日期/Last Update: 2018-01-20